Bristol Myers Squibb And Bain Capital Form New Company To Tackle Unmet Needs In Immunology
29/7 05:57
(RTTNews) - Bristol Myers Squibb (BMY) and Bain Capital have announced the formation of a new independent biopharmaceutical company dedicated to developing innovative therapies for autoimmune diseases with significant unmet patient needs. The newly launched company begins with fi...